What is the drug Dasatinib?
Dasatinib is a medication to treat chronic myelogenous leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome-positive. It is a cancer medicine that slows the growth and spread of cancer cells. Dasatinib is a medication used when Gleevec is no longer efficient on patients or when they suffer too many and too strong side effects. It is registered as one of the World Health Organization’s essential medicines. Bristol-Myers Squibb and Otsuka Pharmaceutical Co, Ltd collaborated to develop Dasatinib.
Wholesalers and manufacturers of Dasatinib:
Dasatinib is manufactured by Bristol Myers Squibb under the brand name of Sprycel, this manufacturer is the only marketing authorization holder. Dasatinib was authorized to enter the EU marketplace in 2006. In Bangladesh, Dasatinib medication is found under the name of Dasanix marketed by Beacon Pharmaceuticals. Dasatinib suppliers market it in the form of oral tablets. You can find tablets of 20mg, 50mg, 70mg, 80mg, 100mg, 140mg. The package for sales is usually 60 tablets. Dasatinib suppliers are globally found, there are around 170 Dasatinib suppliers in China, and 27 in the United States.
Dasatinib for sale:
In the US, the retail prices for one dose of Dasatinib depend on the strength of the tablet, for 20mg it costs around $140 for 50mg and 70 mg it costs around $280 and for tablets of 80,100 and 140 mg it costs $505.
On Pipelinepharma B2B marketplace, Dasatinib is mostly available from the European Union, Argentina, and India. The platform helps Dasatinib distributors to find globally qualified manufacturers through quality control procedures. If you are sourcing for pharmaceutical products such as Dasatinib, our very intuitive search engine will ease your searching by providing you a list of Dasatinib manufacturers. Thanks to Pipelinepharma online platform, you can place orders to proceed with Dasatinib manufacturers.
How to use Dasatinib drug?
The dosage of Dasatinib will depend on the phase the patient is in. For a chronic phase CML for leukemia, the usual dose for an adult is 100mg taken once a day.
The dosage of Dasatinib for accelerated phase CML for Myeloid or Lymphoid, an adult dose is 140 mg taken once a day.
In both cases, Dasatinib drugs must be taken orally, and until the disease shows progression or the patient is intolerant to the medication.
Dasatinib medication can have some side effects, the most common ones are bleeding gums, bloody or black, tarry stools, body aches or pain, burning, tingling, numbness, or pain in the hands, arms, feet, or legs, chest pain.
It must be stored at room temperature, away from heat, moisture, and direct light.